Thanks Mrdog for that information. I was wondering already how...

Thanks Mrdog for that information. I was wondering already how they can report about the results by end of Sept when they need about 3 months from end of trial to analyse and write the report.

If ACL can get a very good result like > 1 year extension, it would be outstanding and SP could go really high. I don't really want to be so excited yet as in the past, I get disappointed. Very positive HHL is still accumulating, I don't really see a lot of sellers as it is just the beginning of the FY so people don't tend to do their balance sheet yet. Sold my few PXS shares last week. So 100% of my portfolio is with ACL. I have lost confidence in investing in small cap Biotech companies. ACL and SRX are the only 2 I keep track. PXS was just a punt in case SP can bounce up but the latest news was really bad plus company keeps on spending like there is no tomorrow. Pete Smith made a good decision to cut cost drastically.